Related-party transactions with SBC Medical Group and others and transaction-integrity risk
First written in FY2022. 2 of 6 entries say "Worsened", first in FY2023. Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025WorsenedAnnual report
「株式会社Japan Medical & Beauty is an entity wholly owned by Yoshiyuki Aikawa, a director of our parent, SBC Medical Group Co., Ltd.」
Product and raw-material sales to Japan Medical & Beauty increased from ¥212.618 million to ¥307.464 million, while receivables rose from ¥48.771 million to ¥88.281 million. The risk disclosure classifies the likelihood as high. - FY2024ReframedAnnual report
「株式会社Japan Medical&Beauty Sales of products and raw materials ¥212.618 million Accounts receivable ¥48.771 million」
The disclosure shifted from loans, provisions and guarantees involving 誠心会 to product and raw-material sales and receivables involving Japan Medical&Beauty, invested in by the largest shareholder. - FY2023WorsenedAnnual report
「Loans ¥60.447 million Long-term loans ¥260.447 million Advertising production and operation, personnel services, etc. ¥29.600 million Provision for doubtful accounts ¥253.520 million Guarantees of obligations ¥133.740 million」
Loans to related party 誠心会 reached ¥260.447 million, with a ¥253.520 million provision for doubtful accounts, ¥29.600 million of service transactions and ¥133.740 million of guarantees disclosed. - FY2023-Q3MaterialisedAnnual report
「Provision for doubtful accounts ¥200.000 million」
A ¥200.000 million long-term loan was recorded from the previous fiscal year-end, while a ¥200.000 million provision for doubtful accounts was recorded at the third-quarter consolidated period-end and recognized as an extraordinary loss. - FY2023-Q1AdvancedAnnual report
「On 18 November 2022, we entered into a business alliance agreement with SBC Medical Group Co., Ltd., represented by Yoshiyuki Aikawa, our major and largest shareholder.」
The related-party relationship with SBC Medical Group was formalized through a business alliance, including CPC operation services and joint development of an ordering system. - FY2022First statedAnnual report
「During the consolidated fiscal year, we newly began related-party transactions with SBC Medical Group Co., Ltd. and the incorporated association 誠心会.」
The company began advertising production and operation transactions of ¥200.000 million with SBC Medical Group and a ¥200.000 million loan to 誠心会, and disclosed risks relating to transaction rationale, pricing and governance.